FMO1 anticorps (AA 1-407)

N° du produit ABIN1885923

Cet anticorps anti-FMO1 est un anticorps Lapin Polyclonal détectant FMO1 dans WB. Adapté pour Humain.

Aperçu rapide pour FMO1 anticorps (AA 1-407) (ABIN1885923)

Antigène: FMO1 (Flavin Containing Monooxygenase 1 (FMO1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FMO1 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-FMO1 anticorps

Épitope: AA 1-407

Purification: Purified by antigen-affinity chromatography.

Immunogène: Recombinant protein fragment contain a sequence corresponding to a region within amino acids 1 and 407 of Human FMO1

Information d'application

Indications d'application: Suggested dilutions:
Western blotting: 1.500-1.3000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.

Agent conservateur: Thimerosal (Merthiolate)

Précaution d'utilisation: Biohazard Informations: This product contains thimerosal which is hazardous.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.

Détails sur FMO1

Antigène: FMO1 (Flavin Containing Monooxygenase 1 (FMO1))

Autre désignation: flavin containing monooxygenase 1

Sujet: Metabolic N-oxidation of the diet-derived amino-trimethylamine (TMA) is mediated by flavin-containing monooxygenase and is subject to an inherited FMO3 polymorphism in man resulting in a small subpopulation with reduced TMA N-oxidation capacity resulting in fish odor syndrome Trimethylaminuria.Three forms of the enzyme, FMO1 found in fetal liver, FMO2 found in adult liver, and FMO3 are encoded by genes clustered in the 1q23-q25 region.Flavin-containing monooxygenases are NADPH-dependent flavoenzymes that catalyzes the oxidation of soft nucleophilic heteroatom centers in drugs, pesticides, and xenobiotics.[provided by RefSeq]

Poids moléculaire: 60 kDa

ID gène: 2326

NCBI Accession: NP_002012, NM_002021